Suiseng Suspension for injection for pigs
Suiseng Suspension for injection for pigs
Mhux awtorizzat
- Escherichia coli, fimbrial adhesin F4ac
- Escherichia coli, fimbrial adhesin F5
- Clostridium perfringens, type C, beta toxoid
- Clostridium novyi, type B, alpha toxoid
- Escherichia coli, fimbrial adhesin F4ab
- Escherichia coli, fimbrial adhesin F6
- Escherichia coli, LT toxoid
Identifikazzjoni tal-prodott
Isem tal-mediċina:
Suiseng Suspension for injection for pigs
Suiseng Vet injektioneste, suspensio
Metodu ta’ amministrazzjoni:
-
Użu għal ġol-muskoli
Dettalji tal-prodott
Sustanza attiva / Qawwa:
-
Disponibbli biss fi English78.00percent1.00Dose
-
Disponibbli biss fi English79.00percent1.00Dose
-
Disponibbli biss fi English35.00percent1.00Dose
-
Disponibbli biss fi English50.00percent1.00Dose
-
Disponibbli biss fi English65.00percent1.00Dose
-
Disponibbli biss fi English80.00percent1.00Dose
-
Disponibbli biss fi English55.00percent1.00Dose
Forma farmaċewtika:
-
Suspensjoni għall-injezzjoni
Withdrawal period by route of administration:
-
Użu għal ġol-muskoli
-
Pig
-
Meat and offal0day
-
-
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
- QI09AB08
Status tal-awtorizzazzjoni:
-
Surrendered
Tagħrif addizzjonali
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
- Laboratorios Hipra S.A.
Awtorità responsabbli:
- Finnish Medicines Agency
Numru tal-awtorizzazzjoni:
- 25275
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
Numru tal-proċedura:
- ES/V/0461/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Kemm kienet utli din il-paġna?: